Raymond James Financial’s Prothena PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
Raymond James Financial's PRTA Position: Q3 2026 in Review
Raymond James Financial increased its Prothena (PRTA) stake by 0.01% in Q3 2026, buying an estimated $9 and bringing the position to 11,447 shares worth $95.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5224.
Raymond James Financial first reported a position in PRTA in Q4 2024 and has held it in 8 quarters since. The position peaked at $215K in Q3 2025. 180 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.
- Raymond James Financial held 11,447 shares of Prothena worth $95.9K as of Q3 2026.
- Raymond James Financial bought 1 Prothena share in Q3 2026, an estimated $9.
- Prothena made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #5224 holding.
- Raymond James Financial first reported a position in Prothena in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's Prothena position peaked at $215K in Q3 2025.
- 180 funds tracked by Wall St. Rank held Prothena as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.